No Debarment. In the course of the Development of the Product, each Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 10 contracts
Samples: License Agreement (Catalyst Biosciences, Inc.), License Agreement (Catalyst Biosciences, Inc.), License and Collaboration Agreement (Menlo Therapeutics, Inc.)
No Debarment. In the course of the Development research or development of the ProductResearch Products, each Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 5 contracts
Samples: Inhaled Collaboration and Option Agreement (Liquidia Technologies Inc), Inhaled Collaboration and Option Agreement (Liquidia Technologies Inc), Inhaled Collaboration and Option Agreement (Liquidia Technologies Inc)
No Debarment. In the course of the Development of the ProductProducts, each neither Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, Authority or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party in writing promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 4 contracts
Samples: License Agreement, License Agreement (Pfenex Inc.), License Agreement (Pfenex Inc.)
No Debarment. In the course of the Development of the Licensed Product, each Party shall not use any employee or consultant who has ever been debarred by any Regulatory Authority, or, to such Party’s knowledge, or is the subject of debarment proceedings or convicted of a crime for which an entity or person could be debarred (including by the FDA under 21 U.S.C. § 335a (or subject to a Regulatory similar sanction of any other Governmental Authority)). Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 3 contracts
Samples: License and Collaboration Agreement (Molecular Partners Ag), Discovery Alliance Agreement (Molecular Partners Ag), License and Collaboration Agreement (Allergan Inc)
No Debarment. In the course of the Development development of the Product, each Party neither party shall not use use, during the Term, any employee or consultant who has been debarred by any Regulatory Authorityregulatory authority, or, to the best of such Partyparty’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authorityregulatory authority.
Appears in 3 contracts
Samples: Collaboration and License Agreement, Licensing Agreement, Collaboration and License Agreement (Viropharma Inc)
No Debarment. In the course of the Development development of the ProductProducts, each Party shall not use use, during the Term, any employee or consultant who has been debarred by any Regulatory Authority, or, to the best of such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 3 contracts
Samples: Co Development and License Agreement (Cell Therapeutics Inc), License Agreement (Tranzyme Inc), Development and Commercialization Collaboration Agreement (Cell Genesys Inc)
No Debarment. In the course of the Development by of the Product, each neither Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, Authority or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 3 contracts
Samples: Exclusive License Agreement (Allarity Therapeutics, Inc.), Exclusive License Agreement (Allarity Therapeutics, Inc.), Exclusive License Agreement (Verrica Pharmaceuticals Inc.)
No Debarment. In the course of the Development of the ProductProducts, each neither Party nor its Affiliates shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s or its Affiliates’ knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its or its Affiliates’ employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 2 contracts
Samples: Collaboration and License Agreement (XOMA Corp), Collaboration and License Agreement (Xoma LTD /De/)
No Debarment. In the course of the Development development of the Product, each Party shall not use use, during the Term, any employee or consultant who has been debarred by any Regulatory Authority, or, to the best of such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 2 contracts
Samples: License Agreement (Celladon Corp), License Agreement (Celladon Corp)
No Debarment. In the course of conducting the Development Research Program and the Exploitation of the ProductProducts hereunder, each neither Party nor its Affiliates shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s or its Affiliates’ knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its or its Affiliates’ employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Allogene Therapeutics, Inc.), Collaboration and License Agreement (Allogene Therapeutics, Inc.)
No Debarment. In the course of the Development of the Licensed Product, each neither Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, Authority or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 2 contracts
Samples: Development and License Agreement (Concert Pharmaceuticals, Inc.), Development and License Agreement (Concert Pharmaceuticals, Inc.)
No Debarment. In the course of the Development of the Licensed Product, each Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 2 contracts
Samples: Development and License Agreement (Virobay Inc), Development and License Agreement (Virobay Inc)
No Debarment. In the course of the Development of Manufacturing the Product, each Party shall not use use, during the term of this Agreement any employee employee, contractor or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledgeBest Knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that of any of its employees employee, contractor or consultants consultant who has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
No Debarment. In the course of the Development of the ProductProducts, each neither Party nor its Affiliates shall not use any employee or consultant who has been is debarred by any Regulatory Authority, or, to such Party’s knowledgeBest Knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its or its Affiliates’ employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
Samples: Collaboration and License Agreement (Clovis Oncology, Inc.)
No Debarment. In the course of the Development Development, Manufacture and Commercialization of the ProductProducts, each neither Party nor any of its Affiliates or Sublicensees shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s or its Affiliates’ knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its or its Affiliates’ or Sublicensees’ employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
Samples: Collaboration and License Agreement (Sangamo Therapeutics, Inc)
No Debarment. In the course of the Development development of the Licensed Product, each Party shall not use any employee or consultant who has been debarred by any Regulatory regulatory Authority, or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory regulatory Authority.
Appears in 1 contract
No Debarment. In the course of the Development development of the ProductProducts, each Party shall not use use, during the Term, any employee or consultant who has been debarred by any Regulatory Authority, or, to the Best Knowledge of such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
Samples: Development and Commercialization Agreement (Clovis Oncology, Inc.)
No Debarment. In the course of the Development development of the each Product, each neither Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to the best of such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
Samples: Non Exclusive Collaboration and License Agreement (Acumen Pharmaceuticals, Inc.)
No Debarment. In the course of the Development of the Product, each Party shall not use use, during the Term, any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledgeBest Knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that of any of its employees employee or consultants consultant who has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Amag Pharmaceuticals Inc.)
No Debarment. In the course of the Development Commercialization of the ProductLicensed Products, each Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
No Debarment. In the course of the Development of the ProductLicensed Products, each Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
No Debarment. In the course of the During Development of the Licensed Product, each neither Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledge, Authority or is the subject of debarment proceedings by a Regulatory Authority. Each Party party shall notify the other Party promptly upon becoming aware that any of its employees an employee or consultants has been debarred or consultant is the subject of a debarment proceedings by any Regulatory Authorityproceeding or has been debarred.
Appears in 1 contract
Samples: Exclusive License Agreement (Vascular Biogenics Ltd.)
No Debarment. In the course of the Development of the ProductLicensed Products, each neither Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, Authority or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
Samples: Exclusive License and Collaboration Agreement (Kindred Biosciences, Inc.)
No Debarment. In the course of the Development development of the Licensed Product, each Party shall not use any employee or consultant who has been debarred by any Regulatory Authorityregulatory authority, or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authorityregulatory authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory regulatory Authority.
Appears in 1 contract
No Debarment. In the course of the Development of the a Licensed Product, each Party shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Impax Laboratories Inc)
No Debarment. In the course of the Development research, development, manufacture and commercialization of the ProductLicensed Products, each neither Party nor its Affiliates or sublicensees shall not use any employee or consultant who has been debarred by any Regulatory Authority, or, to such Party’s knowledge, or is the subject of debarment proceedings by a Regulatory Authority. Each Party shall notify the other Party promptly upon becoming aware that any of its or its Affiliates’ or sublicensees’ employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.
Appears in 1 contract
Samples: Option and License Agreement (Sana Biotechnology, Inc.)
No Debarment. In the course of the Development of the ProductProducts, each neither Party shall not nor its Affiliates will use any employee or consultant who has been is debarred by any Regulatory Authority, or, to such Party’s knowledge, is the subject of debarment proceedings by a Regulatory Authority. Each Party shall will notify the other Party promptly upon becoming aware that any of its or its Affiliates’ employees or consultants has been debarred or is the subject of debarment proceedings by any Regulatory Authority.. 49 ***Confidential Treatment Requested.
Appears in 1 contract
Samples: License and Collaboration Agreement (Clovis Oncology, Inc.)
